Aspiriant LLC’s Danaher DHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$774K Sell
4,080
-415
-9% -$88.4K 0.02% 176
2025
Q4
$1.03M Buy
4,495
+366
+9% +$80.5K 0.03% 156
2025
Q3
$819K Sell
4,129
-465
-10% -$92.5K 0.03% 164
2025
Q2
$908K Sell
4,594
-216
-4% -$41.9K 0.03% 155
2025
Q1
$986K Sell
4,810
-86
-2% -$18.8K 0.03% 141
2024
Q4
$1.12M Sell
4,896
-618
-11% -$152K 0.04% 133
2024
Q3
$1.53M Sell
5,514
-56
-1% -$14.8K 0.06% 110
2024
Q2
$1.39M Sell
5,570
-956
-15% -$242K 0.06% 110
2024
Q1
$1.63M Sell
6,526
-62
-0.9% -$15.1K 0.07% 109
2023
Q4
$1.52M Sell
6,588
-813
-11% -$173K 0.07% 108
2023
Q3
$1.63M Buy
7,401
+97
+1% +$21.6K 0.08% 99
2023
Q2
$1.55M Sell
7,304
-480
-6% -$102K 0.08% 100
2023
Q1
$1.74M Sell
7,784
-224
-3% -$51K 0.09% 95
2022
Q4
$1.88M Buy
8,008
+215
+3% +$49.8K 0.1% 91
2022
Q3
$1.79M Buy
7,793
+186
+2% +$45.5K 0.09% 89
2022
Q2
$1.71M Sell
7,607
-143
-2% -$32.9K 0.08% 89
2022
Q1
$2.01M Sell
7,750
-232
-3% -$58.1K 0.11% 87
2021
Q4
$2.33M Buy
7,982
+25
+0.3% +$6.89K 0.12% 82
2021
Q3
$2.15M Sell
7,957
-124
-2% -$33.8K 0.13% 73
2021
Q2
$1.92M Sell
8,081
-97
-1% -$21.5K 0.11% 75
2021
Q1
$1.63M Sell
8,178
-206
-2% -$41.8K 0.1% 74
2020
Q4
$1.65M Sell
8,384
-667
-7% -$134K 0.11% 75
2020
Q3
$1.73M Sell
9,051
-431
-5% -$76.7K 0.14% 71
2020
Q2
$1.48M Sell
9,482
-647
-6% -$92.9K 0.14% 64
2020
Q1
$1.24M Sell
10,129
-2,382
-19% -$321K 0.12% 67
2019
Q4
$1.7M Sell
12,511
-885
-7% -$112K 0.16% 63
2019
Q3
$1.72M Sell
13,396
-878
-6% -$110K 0.15% 77
2019
Q2
$1.81M Sell
14,274
-1,286
-8% -$152K 0.15% 79
2019
Q1
$1.82M Sell
15,560
-1,889
-11% -$194K 0.15% 82
2018
Q4
$1.59M Sell
17,449
-2,508
-13% -$228K 0.12% 86
2018
Q3
$1.92M Sell
19,957
-1,931
-9% -$176K 0.16% 83
2018
Q2
$1.92M Sell
21,888
-1,089
-5% -$97K 0.16% 82
2018
Q1
$1.99M Buy
22,977
+19,866
+639% +$1.74M 0.17% 76
2017
Q4
$256K Sell
3,111
-24,145
-89% -$1.96M 0.08% 70
2017
Q3
$2.07M Sell
27,256
-3,873
-12% -$287K 0.17% 74
2017
Q2
$2.33M Sell
31,129
-3,795
-11% -$284K 0.2% 72
2017
Q1
$2.65M Sell
34,924
-1,488
-4% -$111K 0.23% 71
2016
Q4
$2.51M Sell
36,412
-1,049
-3% -$72.8K 0.23% 65
2016
Q3
$2.6M Sell
37,461
-16,336
-30% -$1.16M 0.26% 56
2016
Q2
$3.11M Buy
53,797
+850
+2% +$55.6K 0.29% 60
2016
Q1
$3.38M Buy
+52,947
New +$3.16M 0.32% 50

Other funds holding DHR

Aspiriant LLC's DHR Position: Q1 2026 in Review

Aspiriant LLC reduced its Danaher (DHR) stake by 9.2% in Q1 2026, selling an estimated $88.4K and leaving 4,080 shares worth $774K. The position accounts for 0.02% of the portfolio, ranked #176.

Aspiriant LLC first reported a position in DHR in Q1 2016 and has held it in 41 quarters since. The position peaked at $3.38M in Q1 2016. 2,165 funds tracked by Wall St. Rank hold DHR as of Q1 2026.

  • Aspiriant LLC held 4,080 shares of Danaher worth $774K as of Q1 2026.
  • Aspiriant LLC sold 415 Danaher shares in Q1 2026, an estimated $88.4K.
  • Danaher made up 0.02% of Aspiriant LLC's portfolio in Q1 2026, its #176 holding.
  • Aspiriant LLC first reported a position in Danaher in Q1 2016 and has held it in 41 quarters since.
  • Aspiriant LLC's Danaher position peaked at $3.38M in Q1 2016.
  • 2,165 funds tracked by Wall St. Rank held Danaher as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.